Treatment | Number of ovulated follicles/total tested follicles (%) | Number of ovulated follicles/number of follicles with antral-like cavity formation (%) | Number of GVDB oocytes/number of ovulated COCs (%) |
---|---|---|---|
Control (DMSO) | 0/87 (0)a | 0/0 (0)a | 0/0 (0)a |
TNF-α (5 ng/mL) | 0/72 (0)a | 0/0 (0)a | 0/0 (0)a |
Pioglitazone (5 μM) | 0/80 (0)a | 0/0 (0)a | 0/0 (0)a |
FSH (100 mIU/mL) | 60/126 (48)b | 60/81 (74)b | 60/60 (100)b |
FSH + TNF-α (5 ng/mL) | 14/150 (99)c | 14/44 (32)c | 14/14 (100)b |
FSH + TNF-α (5 ng/mL) + pioglitazone (5 μM) | 35/125 (28)d | 35/60 (58)d | 35/35 (100)b |